PortfoliosLab logoPortfoliosLab logo

IUHC.L's Sharpe Ratio of 1.37 indicates that for each unit of volatility, it generates 1.37 units of excess return above the risk-free rate. The ratio is calculated using historical daily returns over the past 12 months (as of Jul 16, 2026).

Sharpe uses total volatility (standard deviation) which includes both upside and downside price movements, making it useful for comparing risk-adjusted returns across different assets. For how to read this number and when it can mislead, see Sharpe Ratio Explained.

IUHC.L Sharpe Ratio Rank


IUHC.L Sharpe Ratio Rank: 47.948
Average

IUHC.L ranks above 47.9% of all investments in our database based on Sharpe Ratio over the past 12 months, showing balanced returns relative to total risk taken. Securities are ranked from 0 (worst) to 100 (best).

What moves the rank

  • Strong returns with low total volatility → Higher rank
  • High volatility (both upside and downside) → Lower rank
  • Consistent returns → Higher rank than volatile returns of same magnitude
  • Sharp drawdowns increase volatility → Lower rank

What you can do with this information

  • Returns are proportional to volatility—neither strong nor weak
  • Evaluate whether the volatility profile aligns with your risk tolerance
  • Review higher-ranked alternatives in the same category
  • Monitor rank direction to identify improving or deteriorating trends

IUHC.L Sharpe Ratio Market Positioning

The chart shows IUHC.L's Sharpe Ratio relative to all ETFs on our platform, with color zones indicating percentile rankings. Higher ratios indicate better risk-adjusted returns.


  • Red zone (bottom 25%): 0.74 or lower
  • Yellow zone (middle 50%): 0.74 to 1.91
  • Green zone (top 25%): 1.91 or higher
  • Top 1%: 6.53+
  • Median: 1.42 — half of all investments score higher

How it compares to other similar ETFs

The table compares iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)'s Sharpe Ratio with other ETFs in the Health & Biotech Equities, S&P 500 category across multiple time periods, showing how IUHC.L's risk-adjusted performance compares to similar funds.

Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jul 16, 2026.


SymbolName1Y Sharpe Ratio5Y Sharpe Ratio10Y Sharpe RatioAll Time Sharpe Ratio
BTEK.LiShares Nasdaq US Biotechnology UCITS ETF2.46
S5EE.LUBS S&P 500 ESG Elite UCITS ETF USD acc2.46
SBIO.LInvesco Nasdaq Biotech UCITS ETF2.43
BTEC.LiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)2.42
BTEE.LiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)2.41
FBT.LFirst Trust NYSE Arca Biotechnology UCITS ETF Acc2.34
GNOG.LGlobal X Genomics & Biotechnology UCITS ETF2.19
GNOM.LGlobal X Genomics & Biotechnology UCITS ETF2.12
SPEP.LInvesco S&P 500 Scored & Screened ETF Acc2.07
S5SD.LUBS ETF (IE) S&P 500 ESG UCITS ETF USD A-dis2.06
IUHC.LiShares S&P 500 Health Care Sector UCITS ETF USD (Acc)1.37

S&P 500 Index

How to choose period

Historical Sharpe Ratio

The chart shows IUHC.L's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when IUHC.L consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.


Loading charts...

Sharpe Ratio Calculator

How does IUHC.L fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio